Hoang Peter L. 4
4 · Marker Therapeutics, Inc. · Filed Oct 23, 2018
Insider Transaction Report
Form 4
Hoang Peter L.
DirectorCEO and President
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-10-19+200,000→ 200,000 total(indirect: By Spouse)Exercise: $9.18Exp: 2028-10-19→ Common Stock (200,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-10-19+1,359,855→ 1,359,855 totalExercise: $9.18Exp: 2028-10-19→ Common Stock (1,359,855 underlying)
Footnotes (2)
- [F1]Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended. These options vest and are exercisable immediately. The option exercise price is the closing price on the date of the grant, October 19, 2018.
- [F2]Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended to Tsvetelina Hoang, Mr. Hoang's wife who serves as the Company's Vice President, Research and Development. One fifth of the shares vest ten months after the grant date, the remainder of the shares vest in monthly installments thereafter upon the continued employment of Dr. Hoang by the Company through the vesting dates. The option exercise price is the closing price on the date of the grant, October 19, 2018.